Nocardiosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Changes made per Mahshid's request |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
In the United States, it has been estimated that 500-1,000 new cases of Nocardia infection occur annually. Approximately 60% of nocardiosis cases are associated with pre-existing immune compromise. Although incidence data are extremely limited, the number of cases is likely rising as a result of the increase in the number of severely immunocompromised persons. | In the United States, it has been estimated that 500-1,000 new cases of Nocardia infection occur annually. Approximately 60% of nocardiosis cases are associated with pre-existing immune compromise. Although incidence data are extremely limited, the number of cases is likely rising as a result of the increase in the number of severely immunocompromised persons. | ||
| Line 11: | Line 10: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category: | |||
[[Category:Bacterial diseases]] | |||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 18:11, 18 September 2017
|
Nocardiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nocardiosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Nocardiosis epidemiology and demographics |
|
Risk calculators and risk factors for Nocardiosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epidemiology and Demographics
In the United States, it has been estimated that 500-1,000 new cases of Nocardia infection occur annually. Approximately 60% of nocardiosis cases are associated with pre-existing immune compromise. Although incidence data are extremely limited, the number of cases is likely rising as a result of the increase in the number of severely immunocompromised persons.